Company Profile

ALTERITY THERAPEUTICS (NASDAQ: ATHE)
3:58 PM EST, 11/15/19
Last: $1.02 Change: -0.04 %Change: -3.30% Volume: 52,966
Detailed Quote
Open: $ 1.02   Volume: 52,966
High: $ 1.02   Yield(%) n/a
Low: $ 0.85   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 15.35M
EPS ($) n/a   Shares Out: 868.80M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -7.83
% Price Change (last 13 weeks): -3.64
% Price Change (last 26 weeks): -34.97
% Price Change (last 52 weeks): -36.46
% Price Change (year to date): -44.79
Management Effectiveness
Return on Equity (%): -75.10
Return on Assets (%): -63.46
Return on Invested Capital (%): -36.22
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $1.11
200-day Moving Average: $1.39
Avg. Daily Vol. (last 50 days): 10,027
Avg. Daily Vol. (last 200 days): 44,755
52-wk high: $2.72
52-wk low: $0.85
Bid: $1.00
Ask: $1.29
Company Information
Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
ALTERITY THERAPEUTICS
460 Bourke Street Level 3
Melbourne VI 3000

Phone: 61.3.9349.4906
Fax: 61.3.9348.0377
http://www.pranabio.com
Per Share Data
Earnings (1year) ($): -0.86
Annual Dividend ($): n/a
Current P/E Ratio (ttm): n/a
Book Value ($): 0.81
Cash Flow ($): -0.61
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 1.62
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 5.98
Current Ratio (x): 5.98
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.00



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2018 Wall Street Horizon, Inc.